Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study

INTRODUCTION: Prolonged glucocorticoid use may increase the risk of adverse safety outcomes, including cardiovascular events. The European League Against Rheumatism and the Canadian Rheumatology Association advise tapering glucocorticoid dose as rapidly as clinically feasible. There is a paucity of...

全面介紹

Na minha lista:
書目詳細資料
發表在:RMD Open
Main Authors: Alten, Rieke, Nüßlein, Hubert, Galeazzi, Mauro, Lorenz, Hanns-Martin, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Pavelka, Karel, Chartier, Mélanie, Poncet, Coralie, Rauch, Christiane, Elbez, Yedid, Le Bars, Manuela
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2016
主題:
Rheumatoid Arthritis
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762207/
https://ncbi.nlm.nih.gov/pubmed/26925253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000228
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍